SOX9 acts as a downstream target of Yes-associated protein 1 (YAP1), which could enhance epithelial-mesenchymal transition (EMT) in gastric cancer [10] and induce cancer stem cell properties in esophageal cancer [11] through the Hippo-YAP pathway. This evidence concerns the gene YAP1 and gastric cancer.